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Abstract
α-Synuclein, an intrinsically-disordered protein associated with Parkinson’s disease, interacts with
mitochondria, but the details of this interaction are unknown. We probed the interaction of α-
synuclein and its A30P variant with lipid vesicles by using fluorescence anisotropy and 19F
nuclear magnetic resonance. Both proteins interact strongly with large unilamellar vesicles whose
composition is similar to that of the inner mitochondrial membrane, which contains cardiolipin.
However, the proteins have no affinity for vesicles mimicking the outer mitochondrial membrane,
which lacks cardiolipin. The 19F data show that the interaction involves α-synuclein’s N-terminal
region. These data indicate that the middle of the N-terminal region, which contains the
KAKEGVVAAAE repeats, is involved in binding, probably via electrostatic interactions between
the lysines and cardiolipin. We also found that the strength of α-synuclein binding depends on the
nature of the cardiolipin acyl side chains. Eliminating one double bond increases affinity, while
complete saturation dramatically decreases affinity. Increasing the temperature increases the
binding of wild-type, but not the A30P variant. The data are interpreted in terms of the properties
of the protein, cardiolipin demixing within the vesicles upon binding of α-synuclein, and packing
density. The results advance our understanding of α-synuclein’s interaction with mitochondrial
membranes.
1. Introduction
Parkinson’s disease and other neurodegenerative disorders are characterized by cytoplasmic
neuronal inclusions known as Lewy bodies [1-4]. α-Synuclein, a 140-amino acid
intrinsically disordered protein, is the main component of Lewy bodies [5-8]. The protein
(Figure 1A) comprises a positively-charged N-terminal region (residues 1-60) with an
imperfect consensus repeat KTKEGV, a hydrophobic middle segment known as the NAC
region (Non Amyloid Component, residues 61-95), and a negatively-charged C-terminal
region (residues 96-140) [9, 10].
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α-Synuclein’s exact functions remain obscure, but recent work highlights its roles in
neurotransmitter release, mitochondrial dysfunction, and aging. One function involves
SNARE-complex assembly at presynaptic vesicles via its C-terminal region while its N-
terminal region is anchored to the vesicle [11]. The protein is important for synaptic activity
when the nerve terminals repeatedly release neurotransmitters, which requires the assembly
and disassembly of the complex.
α-Synuclein localizes not only to the presynaptic neural terminals but also to the
mitochondria, whose membranes are unique in eukaryotes because they contain cardiolipin
(CL), an anionic phospholipid with two phosphatidyl glycerol moieties (Figure 1B). This
localization is associated with mitochondria dysfunction [12-14] including impairment of
complex I [15, 16], oxidative stress [17], mitochondrial lipid abnormalities [16], and
mitochondrial fission [18]. The protein is also involved in aging, but the reasons for its age-
related loss of function are unknown [11]. Here, we focus on interactions with the
mitochondrial membrane.
The interaction of α-synuclein with vesicles of different lipid composition, phospholipid
headgroups, sizes, and surfaces has been studied [19-30]. The protein has a higher affinity
for small unilamellar vesicles than for large unilamellar vesicles (LUVs), and binds more
strongly to vesicles containing anionic phospholipids [10, 19, 20, 31]. However, little
attention has been focused on quantitative assessment of interactions with bilayers that
mimic the lipid compositions of the mitochondrial inner and outer membranes.
We used fluorescence anisotropy and high resolution nuclear magnetic resonance
spectroscopy (NMR) to investigate the interaction of wild-type α-synuclein and one of its
familial Parkinson’s disease variants [32], A30P, with LUVs having lipid compositions
similar to the inner and outer mitochondrial membranes. We evaluated the importance of CL
as well as the effect of saturated and unsaturated CL acyl side chains. We also investigated
the effect of temperature, and using 19F-labeled α-synuclein, we determined which region of
the protein interacts with LUVs containing CL. The results advance our understanding of α-
synuclein’s interaction with mitochondrial membranes.
2. Experimental Procedures
2.1. Expression, Purification, and Labeling of Human α-Synuclein and its A30P Variant
Wild-type α-synuclein, A30P α-synuclein, V3C α-synuclein and V3C;A30P α-synuclein
were expressed from a T7-7 plasmid in Escherichia coli BL21-Gold(DE3) competent cells
(Stratagene Cloning Systems, La Jolla, CA). The proteins were purified as described [33,
34].
The V3C mutation was made by using a Stratagene site-directed mutagenesis kit. The
cysteine was used to attach Alexa Fluor 488 (Invitrogen, Carlsbad, CA). For labeling, 12 mg
of V3C α-synuclein were dissolved in sterile, degassed water to a final concentration of 2
mg/mL. Tris(2-carboxyethyl)phosphine and NaHCO3 were added in a 10-fold molar excess
over the protein. The mixture was incubated at room temperature with shaking for 30 min.
Next, Alexa Fluor 488 C5-maleimide was added in a 10-fold molar excess over the protein
and the mixture incubated at room temperature with shaking for 2 h. The labeled protein was
purified with gel filtration chromatography by using a Superdex 75 column eluted with 20%
acetonitrile in phosphate buffered saline (NaCl 137 mM, KCl 2.7 mM, Na2HPO4 10 mM,
KH2PO4 1.8 mM). The labeled protein was dialyzed against water.
The extinction coefficient of the dye at 494 nm (71,000 M−1cm−1) was used to quantify the
labeled protein. The Lowry method (Pierce, Rockford, IL) was used to quantify the total
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protein. The degree of labeling was 84% for V3C α-synuclein and 99% for V3C;A30P α-
synuclein. Aliquots containing 1 mg of labeled protein were lyophilized and stored at −80
°C.
For NMR experiments, wild-type and Y125F α-synuclein labeled with 3-fluoro-L-tyrosine
were prepared as described [35].
2.2. Cell Culture and Mitochondria Isolation
Human epithelial carcinoma cells (HeLa) from the ATCC were cultured in Dulbelcco’s
modified Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine serum,
penicillin and streptomycin (100 μg/mL). The cultures were incubated at 37 °C in 5% CO2.
Mitochondria were isolated from HeLa cells (2 × 107 cells) by using the Mitochondria
Isolation Kit for Cultured Cells from Pierce (Rockford, IL). Their activity was tested by
assessing the cytochrome c oxidase activity with the Mitochondria Activity Assay Kit from
BioChain Institute, Inc. (Hayward, CA).
2.3. Mitochondrial Import of α-Synuclein
Freshly isolated mitochondria were incubated with fluorescently-labeled α-synuclein in the
presence of energy mixture and transport buffer as described [36]. Trypsin was used to
remove α-synuclein attached to the surface of mitochondria. Mito Tracker Red CMXRos
(Invitrogen) was used to stain the active mitochondria after protein import and
trypsinization. Fused silica and glass microscope slides were prepared as described [37].
Mitochondria containing α-synuclein were allowed to attach to the poly-L-lysine coated
slide for 30 min and then rinsed with minimal media. α-Synuclein import was assessed by
using confocal microscopy on an inverted laser scanning microscope (Zeiss 510 Meta,
Thornwood, NY) equipped with a 63 × 1.4 NA, Plan-Apochromat, oil immersion objective.
2.4. Vesicle Preparation and Characterization
Lipids were purchased from Avanti Polar Lipids, Inc. (Birmingham, AL) in chloroform,
except cholesterol (CH, from ovine wool), which was dissolved in chloroform to a
concentration of 1 mg/mL and stored at −20 °C. The lipids were used without further
purification.
Aliquots of lipids in chloroform, were mixed in glass vials and the solvent removed
overnight in a vacuum concentrator. The dried mixtures were suspended in 1 mL of 50 mM
sodium phosphate buffer, pH 7.4, to a final lipid concentration of 2 mM. The following
lipids were used for preparing LUVs: CH (cholesterol), CL (bovine heart), 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(DOPE), 1′,3′-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-sn-glycerol (TM CL), and 1′,3′-
bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (TO CL). Figure 1B shows the
structures of CLs.
Vesicles of composition DOPC:DOPE:CL:CH 2.0:1.3:1.0:0.6 molar ratio and
DOPC:DOPE:CH 4.0:2.0:0.9, corresponding to inner and outer membrane of mitochondria
[38], respectively, were prepared. LUVs with different ratios of CL (1.0, 0.8, 0.5, and 0) or
different CL acid side chains (TM and TO) were also prepared.
LUVs were prepared by multiple extrusion [20, 31, 39] through a 0.1 μm polycarbonate
membrane (Whatman Inc., Sanford, ME).
For NMR experiments, the vesicles were prepared with the same protocol, but at a
concentration of 4 mM. The dried mixture corresponding to the inner mitochondrial
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membrane was resuspended in 50 mM sodium phosphate buffer, pH 7.4, containing 10%
D2O. The final concentration of 19F labeled protein in the NMR tube was 100 μM and the
protein:lipid molar ratio was ~1:100. Protein in buffer alone was used as a reference.
Vesicles size and its distribution were characterized with dynamic light scattering (Zetasizer
Nano ZS, Malvern Instruments, Southborough, MA). Measurements were performed on
freshly prepared LUVs and LUVs stored for 72 h at 4 °C. The LUV concentration was 2
mM in 50 mM sodium phosphate buffer, pH 7.4. The measurements were performed at 25
°C with the viscosity and refraction index set to those for water.
2.5. NMR
19F spectra were acquired at 25 °C on a Varian Inova 600 MHz spectrometer equipped with
a 5 mm triple resonance probe. The spectra comprised 2048 transients with a 30 kHz sweep
width. The chemical shift was referenced to trifluoroethanol at 0 ppm. The experiments were
conducted in triplicate.
2.6. Fluorescence Anisotropy of Labeled Proteins
The experiments were conducted on a FluoroLog®-322 spectrofluorometer (HORIBA Jobin
Yvon Inc., Edison, NJ) with an excitation wavelength of 495 nm and an emission
wavelength of 519 nm. Four hundred μL of 100 nM protein solution in 50 mM sodium
phosphate buffer, pH 7.4, were titrated with LUVs at 25 or 37 °C.
Each point is the average of five measurements, and each condition was tested in triplicate.
Control measurements using only LUVs or unlabeled wild-type α-synuclein in the same
buffer were performed to assess background fluorescence, which was negligible.
The anisotropy was calculated as described [40]. The dissociation constants (Kd) were
calculated by fitting the data to a one site model (SigmaPlot 11.0).
2.7. DPH Fluorescence Anisotropy
1,6-Diphenyl-1,3,5-hexatriene (DPH) was incubated with LUVs for one h at room
temperature either in the presence or absence of protein. Samples comprised 100 nM protein
and 300 μM LUVs in 50 mM phosphate buffer, pH 7.4. The final molar lipid to DPH ratio
was 300:1. Fluorescence anisotropy was recorded at 25 °C by using an excitation
wavelength of 360 nm and an emission wavelength of 440 nm. Fluorescence anisotropy was
also measured at 37 °C for CL IM LUVs in the presence or absence of wild-type or A30P α-
synuclein. The result for each condition is the average of five measurements.
3. Results
3.1. In vitro Mitochondrial Import of α-Synuclein
Fluorescently-labeled α-synuclein localized in isolated mitochondria (Figure 2A). Mito
Tracker Red CMXRos is an indicator of active mitochondria because its accumulation is
related to membrane potential. The red fluorescence shows that mitochondria are active after
protein import and trypsinization (Figure 2B). Co-localization of fluorescently-labeled
protein and Mito Tracker Red indicates that much of the protein is located outside the matrix
(Figure 2D). These findings are consistent with those of Devi et al. [13]. To understand the
distribution of α-synuclein in the inner and outer membrane, we used lipid vesicles with a
composition similar to these membranes.
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3.2. Interaction with LUVs Having Lipid Compositions Similar to the Inner and Outer
Mitochondrial Membrane
Mitochondria contain 25.3% phospholipid by mass [38]. In terms of composition, the
mitochondria comprise 40.8% phosphatidyl choline, 37.4% phosphatidyl ethanolamine,
19.1% CL, and ~3% phosphatidyl inositol. The major phospholipids of the outer membrane
are phosphatidyl choline (55.2%), and phosphatidyl ethanolamine (25.3%). The major
phospholipids of the inner membrane are phosphatidyl choline (44.5%), phosphatidyl
ethanolamine (27.7%), and CL (21.5%). Although the amount of CL in the outer membrane
is small, the exact value remains controversial [41, 42]. Nevertheless, there is at least 40
times more CL in the inner membrane than in the outer membrane [43].
Fluorescence anisotropy was used to quantify the interaction of fluorescently-labeled V3C
α-synuclein and V3C;A30P α-synuclein with LUVs. Alexa Fluor 488 dye was chosen
because of its high photostability [44]. Labeling at position 3 was selected because this
region is highly dynamic, decreasing the possibility that the modification will disrupt the
native conformation [45]. The average diameter of the LUVs, as determined by dynamic
light scattering, is ~140 nm, consistent with values for vesicles extruded through membranes
with 100 nm pores [20, 31]. The vesicles were stable for at least three days if kept at 4 °C in
50 mM sodium phosphate buffer, pH 7.4. Nevertheless, the vesicles were used within 48 h.
The presence or absence of CH or CL did not affect vesicle size.
First, we studied the interaction of fluorescently-labeled proteins with LUVs having a molar
DOPC:DOPE:Cholesterol (CH) ratio of 4.0:2.0:0.9, which corresponds to the composition
of the outer membrane. No change in the anisotropy was noted when titrating 100 nM
protein with LUVs, suggesting limited affinity of fluorescently labeled V3C or V3C;A30P
α-synuclein for this type of vesicle (Figure 3A and B).
LUVs with a molar ratio corresponding to the inner membrane (DOPC:DOPE:CL:CH,
2.0:1.3:1.0:0.6) gave strikingly different results (Figure 3); both the wild-type protein and
the A30P variant bind with sub mM dissociation constants. As shown in Table 1, V3C α-
synuclein binds slightly more strongly (Kd 130 μM) than the V3C;A30P variant (Kd 210
μM). Since only the inner membrane contains CL, these observations implicate CL in the
binding of α-synuclein and are consistent with studies showing that α-synuclein interacts
with vesicles containing anionic phospholipids [10, 20, 24, 46].
3.3. Importance of CL
α-Synuclein is also mostly associated with the inner membrane of mitochondria in brains
from patients with Parkinson’s disease [13, 15]. In terms of phospholipids, brains of mice
lacking α-synuclein have reduced levels of only CL and phosphatidylglycerol (a CL
precursor) [16]. Since CL is mitochondria-specific, we decided to investigate α-synuclein
binding to LUVs containing different amounts of this phospholipid. The data are shown in
Figures 4, and the Kd values are compiled in Table 1.
LUVs containing DOPC, DOPE, and CH in molar ratios corresponding to the inner
mitochondrial membrane were prepared with 100%, 80%, 50%, and 0% CL, where 100%
represents the normal amount in the inner membrane. For V3C α-synuclein, decreasing the
CL by 20% causes less than a two-fold increase in Kd, but halving the CL increases Kd by a
factor of six. No binding was noted when CL was absent (Figure 4A). These findings show
that CL is essential for the interaction between α-synuclein and the inner mitochondrial
membrane and that the affinity increases with CL concentration.
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We also studied the interaction of the A30P variant with these LUVs. The decrease in
affinity is even stronger for the variant than it is for the wild-type protein (Figure 4B, Table
1).
3.4. Effect of Acyl Group
For the studies described above we used bovine heart CL, whose side chains contain two
double bonds, one between C6 and C7, the other between C9 and C10 (Figure 1B). In brain
CL, however, oleic acid, which has only the former double bond, is the most abundant fatty
acid [47]. To examine the effect of side chain saturation on α-synuclein binding, LUVs with
a molar ratio corresponding to the lipid composition of the inner membrane were prepared
by using TOCL, with its four oleic acid chains (Figure 1B).
The results are shown in Figure 5, and the Kd values are compiled in Table 1. The V3C
variant binds LUVs with the more abundant side chain more strongly (Kd 67 μM) than
LUVs containing two double bonds (Kd 130 μM).
The affinity of A30P α-synuclein for LUVs containing one double bond per side chain (Kd
153 μM) is nearly the same as its affinity for LUVs with two (Kd 210 μM). We conclude
that α-synuclein prefers the LUVs with compositions that most closely mimic those from
brain mitochondria.
3.5. Positional Information
Since V3C α-synuclein and V3C;A30P α-synuclein are labeled with the dye at a single
position (Figure 1A), the fluorescence anisotropy studies provide information about protein
binding, but not positional information.
19F NMR was used to test the effect of chain saturation and to determine if the specific
regions of α-synuclein bind differently. 19F is sensitive to its environment, such that small
changes in the structure of a labeled region are easily detected.
α-Synuclein has four tyrosines, one at position 39 in the N-terminal region and the others
near the C-terminus at positions 125, 133, and 136 (Figure 1A). The 19F NMR spectrum of
3-fluoro-tyrosine-labeled wild-type α-synuclein in buffer alone exhibits only three
resonances (Figure 6A). As shown by Li et al., [35], the middle resonance is a composite of
resonances from tyrosines 39 and 125. We used the Y125F variant to eliminate the overlap
(Figure 6 B).
Spectra acquired in the presence of vesicles containing CL with two (CL), one (TO), and no
(TM) double bonds are shown in Figure 6 C, D, and E, respectively. The spectra in panels C,
D and E are similar despite the differences in affinity (Table 1). This is because the high
concentrations required for NMR result in almost complete binding for all samples despite
the difference in Kd values. The fact that the resonances from positions 133 and 136 are
unchanged by the LUVs, but the resonance from position 39 decreases (Figure 6C-E),
indicates that N-terminal region of the protein interacts with the vesicles.
3.6. Temperature and Binding
Table 1 shows the affinities at 25 °C (Figure 3A and B) and 37 °C (Figure 7) of
fluorescently-labeled V3C α-synuclein and V3C;A30P α-synuclein for LUVs with a
composition corresponding to the inner membrane. The affinity of V3C α-synuclein is two
fold greater (Kd 59 μM) at 37 °C than it is at 25 °C (Kd 134 μM), but the affinity of the
V3C;A30P protein is unaffected.
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3.7. DPH Fluorescence Anisotropy
The fluorescence anisotropy of DPH was used to examine the packing density of LUVs with
different CL acyl side chains. The anisotropy depends on the type of phospholipid and its
degree of saturation with higher packing density causing larger anisotropy.
The data (Figure 8) indicate that in buffer, at 25 °C, LUVs containing CL with one double
bond (TO CL) are as well packed as those containing two double bonds (CL), but both are
better packed than LUVs with completely saturated cardiolipin (TM CL).
Wild-type and A30P α-synuclein reduce the anisotropy for all three types of LUVs. The
decrease is comparable for wild-type and A30P α-synucleins. Studies conducted at 37 °C
also show a decrease in anisotropy for CL IM vesicles in the presence of both wild-type and
A30P α-synuclein (Figure 8, inset). These data show that α-synuclein perturbs the packing
density.
4. Discussion
α-Synuclein interacts with isolated mitochondria from HeLa cells and is imported in the
proximity of the inner membrane (Figure 2). The protein has no affinity for LUVs with the
lipid composition of the outer mitochondrial membrane (Table 1), which lacks CL. This
observation is consistent with studies showing that α-synuclein enters mitochondria via the
protein import channel [15] rather than through lipid interactions.
A significant affinity was noticed for both the wild-type protein and the A30P variant for
LUVs with a composition similar to that of the inner mitochondrial membrane, with the
V3C α-synuclein having slightly higher affinity (Figure 3). Vesicles with the lipid
composition of the IM, except that they lack CL, do not bind α-synuclein. Consistent with
this conclusion, decreasing the CL content reduces α-synuclein affinity (Figure 4A and B).
These observations show the importance of CL in the inner mitochondrial membrane for α-
synuclein localization.
Our data and those of others show that α-synuclein binds more tightly to vesicles containing
anionic phospholipids such as phospahtidylglycerol or phosphatidylserine showing that
anionic character is important for protein binding [10, 19, 20, 30, 31]. The fact that the
protein has a higher affinity for smaller vesicles suggests that membrane curvature [21] or
packing also plays a role. Unfortunately, we cannot tease these apart because cardiolipin is
not just negatively charged, it also affects membrane curvature [17, 48], has limited
miscibility in bilayers [49], and can cause protein clustering [50]. Furthermore, charge
neutralization upon α-synuclein binding also accentuates curvature and causes demixing
[29]. In addition, the protein may be binding membrane defects arising from the poorer
packing of vesicles. For these reasons, we cannot distinguish the effects of charge alone
from the effects of charge combined with changes in curvature, demixing, and packing.
The 19F NMR data suggest that only the N-terminal region interacts with the vesicles.
Others have shown that this region interacts with phospholipid head groups forming an α-
helix, while the C-terminus remains unstructured [20, 21, 24, 25]. The A30P variant has a
lower affinity for anionic lipid vesicles compared to the wild-type protein (Table 1) as has
been reported by others [26, 27, 30, 51]. These observations are consistent with the idea that
proline at position 30, interrupts the helix in the vesicle bound protein [46].
The increased affinity at higher temperature observed for the wild-type protein indicates that
binding is endothermic, which means the interaction of the protein with membranes is
entropically favorable. This observation together with the NMR data lead to the suggestion
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that the nonpolar strip in the amphipathic N-terminal helix region of the protein [25] adds to
the protein’s affinity vesicles via hydrophobic interactions. However, the temperature
dependence could also be brought about by demixing (i.e., differential enrichment of lipids).
In summary, α-synuclein and the A30P variant have a significant affinity for lipid vesicles
with the composition of the inner mitochondrial membrane, but they do not interact with the
vesicles mimicking the outer membrane. The interaction with vesicles mimicking the inner
membrane probably involves electrostatic interactions between the cationic lysines in the
consensus repeat KTKEGV and the anionic cardiolipin.
The increased affinity of α-synuclein for LUVs made from phospholipids with unsaturated
side chains was confirmed [16]. However, in our study α-synuclein binds more strongly to
the TO CL, which contains one double bond per acyl side chain compared to the CL, which
contains two. This observation is interesting in light of the fact that most of the CL in brain
mitochondria possesses one saturated and one unsaturated side chain [47], and is consistent
with a role for CL-α-synuclein interactions in Parkinson’s disease.
To better understand the affinity of α-synucleins for CL vesicles containing different fatty
acids we investigated the vesicle packing density by using DPH fluorescence anisotropy.
The fluorescence anisotropy of DPH embedded in a LUV provides information about
membrane fluidity, and hence the packing density of its acyl side chains. High packing
density lowers fluidity, increasing DPH anisotropy [52].
The DPH anisotropy decreases when wild-type or A30P α-synucleins were added to LUVs
containing CL with one, two, or no double bonds, and the percent decrease is similar in both
instances (Figure 8). Specifically, a 16% decrease was noted for TO CL in the presence of
wild-type α-synuclein while an 11% decrease was noted for TM CL. Also, given the
dissociation constants (Table 1), more protein interacts with TO CL LUVs than with TM CL
LUVs. From these observations we suggest that the binding of α-synuclein to TO CL
vesicles induces demixing of CL, causing defects at the membrane-water interface
(unsaturated acyl chains are more dynamic than saturated chains [53]). We also suggest that
the higher affinity of α-synuclein for TO CL arises from the formation of an amphipathic α-
helix, with the nonpolar residues interacting with nonpolar lipids in the defects, as has been
observed [28].
The DPH anisotropy decreases when wild-type or A30P α-synucleins were added to LUVs
containing CL with one, two, or no double bonds (Figure 8). The trend in DPH fluorescence
anisotropies follows the trend in binding constants (Table 1) indicating that stronger binding
leads to decreased DPH anisotropy. We suggest that this trend follows from the geometry of
CL, which has two small head groups and four acyl chains. The combination of the small
head groups and the large volume of the chains force the molecule into a cone-shaped
structure [54]. This arrangement enhances structural rigidity [53], allowing other molecules
in the membranes to penetrate the bilayer. For TM CL, we conjecture that its saturated
chains interact with the acyl side chains from the other lipids and the cholesterol to maintain
the membrane in a more solvent exposed structure, while for TO CL and IM CL, the
unsaturated acyl chains are more dynamic and able to adjust to a more compact, better
packed structure upon mixing with other components.
Increasing the temperature increases the fluidity of the vesicles, reducing their packing
density. Binding of wild-type protein is stronger at 37 °C than it is at 25 °C. The stronger
binding at higher temperature is consistent with our conclusion about membrane
destabilization by α-synuclein binding. However, as discussed above, the temperature
dependence is also consistent with the idea that hydrophobic interactions play an important
role in binding.
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To our knowledge, this is the first study to investigate the affinity of α-synuclein for lipid
vesicles with a composition similar to mitochondrial membranes. The data explain why α-
synuclein has a high affinity for the inner membrane (it contains CL), show that the
interaction involves the N-terminal region of the protein, and suggest that the protein
destabilizes the inner membrane. An interesting and potentially biologically important
caveat to more detailed interpretation of our data arises from results showing the limited
miscibility of CL in bilayers [49]. Specifically, we cannot know whether the interactions
involve the entire vesicle surface or distinct CL-rich domains – i.e., so-called lipid rafts [55].
The combination of techniques used here, can also be applied to monitor the binding of α-
synuclein to isolated mitochondria and mitoplasts. Such investigations should help elucidate
the role of α-synuclein in the mitochondria dysfunction associated with neurodegenerative
diseases.
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α-Synuclein binds the inner mitochondrial membrane, not the outer membrane
Head group charge and side-chain saturation are important
Quantitative, atomic-level interactions of α-synuclein with mitochondria
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Schematic representation of α-synuclein (A) showing the four tyrosines (red), the position
labeled with dye (green), and the A30P point mutation (blue). (B) Structural formulas of the
CLs used to prepare LUVs. NAC refers to the non amyloid component of α-synuclein.
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Isolated mitochondrion from HeLa cells incubated with fluorescently-labeled α-synuclein
(A), and Mito Tracker Red (B), differential interference contrast (C), and the merged images
(D).
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Interaction of fluorescently-labeled V3C (A) and V3C;A30P (B) α-synucleins with LUVs
having a composition similar to that of the inner (엯) and outer (●) membranes. Error bars
represent the standard deviations from triplicate experiments.
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Differential binding affinity of fluorescently labeled- V3C (A) and - V3C;A30P (B) α-
synucleins to LUVs having a composition similar to the inner membrane but varying
amounts of CL. Error bars represent the standard deviations from triplicate experiments.
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Binding of fluorescently labeled- V3C (A) and - V3C;A30P (B) α-synucleins to LUVs with
a composition similar with inner membrane but different degrees of side chain saturation.
Error bars represent the standard deviations from triplicate experiments.
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19F NMR spectra of tyrosine labeled wild-type (A) and Y125F (B) α-synuclein in buffer and
the labeled Y125F variant in the presence of LUVs containing 100% CL (C), TO CL (D),
and TM CL (E). Assignments are shown above the resonances [35]. The molar ratio of
protein to lipid is ~1:100.
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Interaction of fluorescently-labeled-V3C α-synuclein and -V3C;A30P α-synuclein with
LUVs having a composition similar to the inner membrane at 37 °C. Error bars represent the
standard deviations from triplicate experiments.
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DPH anisotropy upon the interaction of α-synucleins with LUVs having different CL acyl
side chains at 25 °C. The inset shows the DPH anisotropy in CL IM LUVs in the presence
and absence of α-synucleins at 37 °C. Error bars represent the standard deviations from 5
experiments.
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